Literature DB >> 29569722

Etiology of hepatocellular carcinoma in West Africa, a case-control study.

Antoine Jaquet1,2, Boris Tchounga1,2,3, Aristophane Tanon4, Aklesso Bagny5, Didier K Ekouevi1,2,3,6, Hamar A Traore7, Annie J Sasco1,2, Moussa Maiga8, François Dabis1,2.   

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer in West Africa where HBV infection is endemic. However, limited information is available on other risk factors such as alcohol use, HCV and HIV infection. A case-control study was conducted in referral hospitals of Abidjan (Cote d'Ivoire), Bamako (Mali) and Lome (Togo). Cases were matched with controls on age, gender and participating site. The diagnosis of HCC relied on the combination of one or more space-occupying lesions suggestive of an HCC on a standardized abdominal ultrasound and an α-fetoprotein level ≥400 ng/ml. HIV, HBV and HCV serology were performed. Hazardous alcohol use was assessed using the AUDIT questionnaire. A conditional logistic regression model was used to measure odds ratio (OR) with their 95% confidence intervals (CI). A total of 160 cases and 320 controls were included. Cases were predominantly men (80.0%) with a median age of 47 years (IQR 38-57). Hazardous alcohol use (OR = 4.5 [CI 1.1-18.5]), HBV infection (OR = 62.5 [CI 20.5-190.7]) and HCV infection OR = 35.9 [CI 10.0-130.3]) were independently associated with HCC. Combining the effect of HBV infection and alcohol, HBV-infected hazardous drinkers had an OR = 149.8 (CI 13.5-1 667.0), HBV mono-infected had an OR = 57.4 (CI 18.8-175.3) (ref: HBV-negative). Aside the independent association of alcohol use and HBV and HCV infection with HCC, a synergic effect between alcohol use and HBV infection was identified. Timely screening and care of HBV infection and hazardous drinking might prevent a significant number of HCC in West Africa.
© 2018 UICC.

Entities:  

Keywords:  Africa; HIV; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma

Mesh:

Year:  2018        PMID: 29569722      PMCID: PMC6041181          DOI: 10.1002/ijc.31393

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

1.  Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  W Ray Kim; Rohit Loomba; Thomas Berg; Raul E Aguilar Schall; Leland J Yee; Phillip V Dinh; John F Flaherty; Eduardo B Martins; Terry M Therneau; Ira Jacobson; Scott Fung; Selim Gurel; Maria Buti; Patrick Marcellin
Journal:  Cancer       Date:  2015-07-15       Impact factor: 6.860

Review 2.  Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach.

Authors:  Maud Lemoine; Serge Eholié; Karine Lacombe
Journal:  J Hepatol       Date:  2014-10-16       Impact factor: 25.083

3.  Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia.

Authors:  Yusuke Shimakawa; Maud Lemoine; Harr Freeya Njai; Christian Bottomley; Gibril Ndow; Robert D Goldin; Abdoulie Jatta; Adam Jeng-Barry; Rita Wegmuller; Sophie E Moore; Ignatius Baldeh; Makie Taal; Umberto D'Alessandro; Hilton Whittle; Ramou Njie; Mark Thursz; Maimuna Mendy
Journal:  Gut       Date:  2015-07-16       Impact factor: 23.059

4.  The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States.

Authors:  Vikrant V Sahasrabuddhe; Meredith S Shiels; Katherine A McGlynn; Eric A Engels
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

Review 5.  Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma.

Authors:  M Colombo
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

6.  Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection.

Authors:  C M Lee; S N Lu; C S Changchien; C T Yeh; T T Hsu; J H Tang; J H Wang; D Y Lin; C L Chen; W J Chen
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

7.  The impact of alcohol consumption on African people in 2012: an analysis of burden of disease.

Authors:  Carina Ferreira-Borges; Jürgen Rehm; Sónia Dias; Thomas Babor; Charles D H Parry
Journal:  Trop Med Int Health       Date:  2015-11-05       Impact factor: 2.622

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

Review 10.  Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Alexander J Stockdale; Mas Chaponda; Apostolos Beloukas; Richard Odame Phillips; Philippa C Matthews; Athanasios Papadimitropoulos; Simon King; Laura Bonnett; Anna Maria Geretti
Journal:  Lancet Glob Health       Date:  2017-10       Impact factor: 26.763

View more
  6 in total

1.  Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.

Authors:  Sheng Zhang; Jiakai Jiang; Weifeng Tang; Longgen Liu
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

2.  Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case-control study.

Authors:  Sheng Zhang; Jing Lin; Jiakai Jiang; Yu Chen; Weifeng Tang; Longgen Liu
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

3.  Limited Awareness of Hepatitis B but Widespread Recognition of Its Sequelae in Rural Senegal: A Qualitative Study.

Authors:  Sokhna Boye; Yusuke Shimakawa; Muriel Vray; Tamara Giles-Vernick
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 3.707

4.  Hepatocellular carcinoma in Ghana: a retrospective analysis of a tertiary hospital data.

Authors:  Kenneth Tachi; Adwoa Agyei-Nkansah; Timothy Archampong
Journal:  Pan Afr Med J       Date:  2020-05-28

5.  DNA methylation biomarkers for hepatocellular carcinoma.

Authors:  Guorun Fan; Yaqin Tu; Cai Chen; Haiying Sun; Chidan Wan; Xiong Cai
Journal:  Cancer Cell Int       Date:  2018-09-17       Impact factor: 5.722

6.  Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.

Authors:  Donatien Serge Mbaga; Sebastien Kenmoe; Cyprien Kengne-Ndé; Jean Thierry Ebogo-Belobo; Gadji Mahamat; Joseph Rodrigue Foe-Essomba; Marie Amougou-Atsama; Serges Tchatchouang; Inès Nyebe; Alfloditte Flore Feudjio; Ginette Irma Kame-Ngasse; Jeannette Nina Magoudjou-Pekam; Lorraine K M Fokou; Dowbiss Meta-Djomsi; Martin Maïdadi-Foudi; Sabine Aimee Touangnou-Chamda; Audrey Gaelle Daha-Tchoffo; Abdel Aziz Selly-Ngaloumo; Rachel Audrey Nayang-Mundo; Jacqueline Félicité Yéngué; Jean Bosco Taya-Fokou; Raoul Kenfack-Momo; Efietngab Atembeh Noura; Cynthia Paola Demeni Emoh; Hervé Raoul Tazokong; Arnol Bowo-Ngandji; Carole Stéphanie Sake; Etienne Atenguena Okobalemba; Jacky Njiki Bikoi; Richard Njouom; Sara Honorine Riwom Essama
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.